Produkty 90746-94-4

CAS 90746-94-4 występuje w naszej ofercie pod nazwami: 4-Hydroxyestradiol 3-O-Beta-D-Glucuronide, 4-Hydroxyestradiol 3-O-b-D-Glucuronide, 4-Hydroxyestradiol-3-O-b-D-glucuronide. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 1mg, 2,5mg, 5mg, 2mg.

4-Hydroxyestradiol 3-O-Beta-D-Glucuronide
TRC
  • opakowanie: 1mg, 2,5mg
  • Warianty: 2
Zobacz produkt
4-Hydroxyestradiol 3-O-b-D-Glucuronide
TRC
  • opakowanie: 5mg
  • Warianty: 1
Zobacz produkt
4-Hydroxyestradiol-3-O-b-D-glucuronide
Biosynth
  • opakowanie: 2mg, 1mg, 5mg
  • Warianty: 3
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,3S,4S,5R,6S)-6-[[(8R,9S,13S,14S,17S)-4,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid (CAS 90746-94-4) to związek chemiczny o wzorze sumarycznym C24H32O9 i masie molowej 464.5 g/mol. Nazwa systematyczna IUPAC: (2S,3S,4S,5R,6S)-6-[[(8R,9S,13S,14S,17S)-4,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid. InChIKey: HGCOILRQOIIUJW-ICTMVFLBSA-N.

Dane identyfikacyjne
Wzór sumarycznyC24H32O9
Masa molowa464.5 g/mol
Nazwa IUPAC(2S,3S,4S,5R,6S)-6-[[(8R,9S,13S,14S,17S)-4,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
InChIKeyHGCOILRQOIIUJW-ICTMVFLBSA-N
SMILESC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 4-Hydroxyestradiol 3-O-b-D-Glucuronide, 4-Hydroxyestradiol 3-O-Beta-D-Glucuronide, 4-hydroxyestradiol 3-glucuronide, 4-hydroxy-17beta-estradiol 3-glucuronide, 4-hydroxy-17beta-estradiol 3-beta-glucuronide, 4-hydroxy-17beta-estradiol 3-(beta-D-glucuronide), 4-hydroxy-17beta-estradiol 3-O-(beta-D-glucuronide), 4,17beta-dihydroxyestra-1(10),2,4-trien-3-yl beta-D-glucopyranosiduronic acid
Izomery (ten sam wzór sumaryczny)
(2S,3S,4S,5R,6R)-6-[[(8R,9S,13S,14S,16R,17R)-3,16-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C24H32O9
(2S,3S,4S,5R,6S)-6-[[(8R,9S,13S,14S,16R,17R)-16,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C24H32O9
(2S,3S,4S,5R,6R)-6-[[(8R,9S,13S,14S,16R,17R)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C24H32O9